Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

833 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Financial Burden of Localized and Metastatic Bladder Cancer.
Scilipoti P, Moschini M, Li R, Lerner SP, Black PC, Necchi A, Rouprêt M, Shariat SF, Gupta S, Morgans AK, Psutka SP, Kamat AM. Scilipoti P, et al. Among authors: kamat am. Eur Urol. 2024 Dec 26:S0302-2838(24)02744-1. doi: 10.1016/j.eururo.2024.12.002. Online ahead of print. Eur Urol. 2024. PMID: 39730299 Review.
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer.
Taylor J, Kamat AM, Annapureddy D, Khene ZE, Howard J, Tan WS, McElree IM, Facundo D, Yim K, Harrington S, Dyer E, Black AJ, Kanabur P, Roumiguié M, Lerner S, Black PC, Raman J, Preston M, Steinberg G, Huang W, Li R, Packiam VT, Woldu SL, Lotan Y, O'Donnell MA. Taylor J, et al. Among authors: kamat am. Eur Urol Oncol. 2024 Dec 17:S2588-9311(24)00288-8. doi: 10.1016/j.euo.2024.12.005. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39694798
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review.
Crupi E, Costa de Padua T, Marandino L, Fallara G, Pederzoli F, Cimadamore A, Goetz EC, Cigliola A, Patané DA, Mercinelli C, Tateo V, Salonia A, Briganti A, Montorsi F, Meeks JJ, Spiess PE, Alhalabi O, Gao J, Kamat AM, Grivas P, Necchi A, Raggi D. Crupi E, et al. Among authors: kamat am. JCO Precis Oncol. 2024 Dec;8:e2400470. doi: 10.1200/PO-24-00470. Epub 2024 Dec 3. JCO Precis Oncol. 2024. PMID: 39626158 Review.
Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer.
Lerner SP, Tangen C, Svatek RS, Daneshmand S, Pohar KS, Skinner E, Schuckman A, Sagalowsky AI, Smith ND, Kamat AM, Kassouf W, Plets M, Bangs R, Koppie TM, Alva A, La Rosa FG, Pal SK, Kibel AS, Canter DJ, Thompson IM Jr; SWOG S1011 Trial Investigators. Lerner SP, et al. Among authors: kamat am. N Engl J Med. 2024 Oct 3;391(13):1206-1216. doi: 10.1056/NEJMoa2401497. N Engl J Med. 2024. PMID: 39589370 Free PMC article. Clinical Trial.
Unmet Need in Non-muscle-invasive Bladder Cancer Failing Bacillus Calmette-Guérin Therapy: A Systematic Review and Cost-effectiveness Analyses from the International Bladder Cancer Group.
D'Andrea D, Mostafid H, Gontero P, Shariat S, Kamat A, Masson-Lecomte A, Burger M, Rouprêt M. D'Andrea D, et al. Among authors: kamat a. Eur Urol Oncol. 2024 Nov 12:S2588-9311(24)00242-6. doi: 10.1016/j.euo.2024.10.012. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39550339 Free article. Review.
Reply to Wen-Wei Sung's Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.06.011.
Tan WS, O'Donnell M, Li R, Kamat AM, Packiam VT. Tan WS, et al. Among authors: kamat am. Eur Urol Oncol. 2023 Oct 26:S2588-9311(23)00225-0. doi: 10.1016/j.euo.2023.10.009. Online ahead of print. Eur Urol Oncol. 2023. PMID: 39492318 No abstract available.
833 results